| Align Technology | 11,120.00 / +4.32% |
| Date/Time | 01/12 / 00:00 |
| Chg. / Chg.(%) | 460.00 / +4.32% |
| Bid | - |
| Ask | - |
| Open | 11,120.00 |
| Previous Close | 10,660.00 |
| High | 11,120.00 |
| Low | 11,120.00 |
| Volume [MXN] | - |
| Volume [Units] | 8 |
| Price fixings | |
| ISIN | US0162551016 |
| Security | ALGN |
| Exchange | Mexico |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 473.05 |  |
|
| NASDAQ | 567.2300 |  |
551,686 |
| IEX | 567.37 | |
35,753 |
| Cboe US | 567.33 | |
33,760 |
| TradeGate | 470.00 | |
160 |
| Xetra | 459.45 | |
104 |
| London Inter.. | 551.25 |  |
31 |
| Stuttgart | 468.500 | |
26 |
| gettex | 467.700 | |
7 |
| Frankfurt | 458.8500 | |
5 |
| München | 454.25 | |
0 |
| Düsseldorf | 453.95 | |
0 |
| Berlin | 453.70 | |
0 |
| Vienna Globa.. | 460.65 | |
0 |
| Mexico | 11,120.00 | |
8 |
News
- The new name and governance of Stellantis take effect
20:25 - GlobeNewswire - ROSEN, A LEADING LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – GDRX
16:00 - GlobeNewswire - Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
16:00 - GlobeNewswire - ROSEN, A TRUSTED LAW FIRM, Reminds Covia Holdings Corporation f/k/a Fairmount Santrol Holdings Inc. Investors of Important February 8 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CVIAQ, CVIA, FMSA
15:00 - GlobeNewswire - Align Technology to Announce Fourth Quarter and 2020 Results on February 3, 2021
01/04/2021 / 14:30 - GlobeNewswire
Real-time